Stocks


 ASX 200 Financial Shock: Can This Stock Rebound After Sharp Fall?

ASX 200 Financial Shock: Can This Stock Rebound After Sharp Fall?

April 23, 2026 10:07 AM AEST| By Sam

Generation Development shares fall sharply after its update, despite strong funds growth and inflows, highlighting a gap between market sentiment and underlying operational momentum in the financial sector.

 ASX Gold Explorer Moves: What Felix Gold’s New Share Listing Means

ASX Gold Explorer Moves: What Felix Gold’s New Share Listing Means

April 23, 2026 10:03 AM AEST| By Sam

Felix Gold lists new shares to support exploration growth, highlighting ongoing reliance on capital markets, limited dilution impact, and continued activity within the Australian mining sector.

 ASX Travel Split: Are Webjet and Web Travel Worth Watching Now?

ASX Travel Split: Are Webjet and Web Travel Worth Watching Now?

April 23, 2026 10:00 AM AEST| By Sam

Webjet and Web Travel Group navigate a challenging travel environment, with consumer sensitivity and global diversification shaping their performance amid cost pressures, economic uncertainty, and evolving sector dynamics.

 ASX 200 Retail Giant Rally: Is Woolworths Running Ahead of Value?

ASX 200 Retail Giant Rally: Is Woolworths Running Ahead of Value?

April 23, 2026 09:54 AM AEST| By Sam

Woolworths gains momentum on strong performance and supply chain investments, but valuation concerns emerge as the share price trades above estimates, reflecting a balance between growth expectations and market sentiment.

 Next Hub24? This ASX Tech Stock Is Turning Heads

Next Hub24? This ASX Tech Stock Is Turning Heads

April 23, 2026 09:43 AM AEST| By Sam

Praemium gains attention as improving platform inflows, client renewals, and stabilisation across operations strengthen its recovery narrative within the evolving Australian fintech and wealth platform sector.

 Syrah Resources (ASX:SYR) Under Pressure In The All Ordinaries on Revised Forecasts

Syrah Resources (ASX:SYR) Under Pressure In The All Ordinaries on Revised Forecasts

April 23, 2026 08:05 AM AEST| By Sam

All ordinaries coverage examines Syrah Resources Limited, detailing forecast revisions, evolving revenue expectations, and positioning within the graphite and materials sector landscape.

 Is American Uranium (ASX:AUZ) shaping All Ords moves?

Is American Uranium (ASX:AUZ) shaping All Ords moves?

April 22, 2026 09:11 PM AEST| By Sam

American Uranium’s entitlement offer activity highlights uranium sector dynamics, reflecting how capital initiatives and exploration developments shape resource-driven trends in Australian equities.

 Metro Mining All Ords Resource Update in Focus

Metro Mining All Ords Resource Update in Focus

April 22, 2026 09:07 PM AEST| By Sam

Metro Mining’s Bauxite Hills update reflects resource sector activity, highlighting how mining developments contribute to All Ordinaries market composition and broader equity trends.

 Is Yancoal (ASX:YAL) impacting ASX 300 coal trends?

Is Yancoal (ASX:YAL) impacting ASX 300 coal trends?

April 22, 2026 07:33 PM AEST| By Sam

Yancoal’s Collie mine adjustments highlight coal sector dynamics, reflecting how operational and workforce changes influence broader resource activity in Australian equities.

 ASX Healthcare Boost: Positive Phase 3 Inspection Lifts Sentiment

ASX Healthcare Boost: Positive Phase 3 Inspection Lifts Sentiment

April 22, 2026 06:46 PM AEST| By Sam

A positive Phase 3 regulatory inspection strengthens confidence in clinical progress, supporting the pathway towards approval and highlighting the importance of compliance in healthcare sector developments.

 ASX Healthcare Watch: Little Green Pharma Shares in Focus After Scheme Update

ASX Healthcare Watch: Little Green Pharma Shares in Focus After Scheme Update

April 22, 2026 06:37 PM AEST| By Sam

Little Green Pharma releases a scheme update, signalling ongoing corporate restructuring while highlighting transparency and strategic developments within the evolving healthcare sector.

 Bounty Oil S&P All Ordinaries Slide Draws Market Focus

Bounty Oil S&P All Ordinaries Slide Draws Market Focus

April 22, 2026 06:36 PM AEST| By Sam

Bounty Oil & Gas highlights energy sector dynamics within the All Ordinaries, reflecting how operational developments and broader market conditions shape Australian equity trends.

 Leadership Update: What Genesis Energy’s Disclosure Signals

Leadership Update: What Genesis Energy’s Disclosure Signals

April 22, 2026 06:33 PM AEST| By Sam

Genesis Energy releases a disclosure notice highlighting governance transparency, with updates focused on leadership reporting requirements rather than operational changes within the utilities sector.

 ASX 200 Tech Comeback: Why Xero Is Back in Focus

ASX 200 Tech Comeback: Why Xero Is Back in Focus

April 22, 2026 06:29 PM AEST| By Sam

Xero’s recovery is driven by strong subscriber growth, improving margins, AI integration, and a shift towards profitability, positioning the company strongly within the evolving technology landscape of the Australian market.

 ASX 200 Entry: Does 4DMedical’s Upgrade Change the Story?

ASX 200 Entry: Does 4DMedical’s Upgrade Change the Story?

April 22, 2026 05:55 PM AEST| By Sam

4DMedical’s ASX 200 inclusion boosts visibility and liquidity, but funding needs and commercial adoption of its lung imaging technology remain key factors shaping its evolving risk and growth narrative.

 Next DroneShield? This ASX Defence Tech Is Gaining Attention

Next DroneShield? This ASX Defence Tech Is Gaining Attention

April 22, 2026 05:43 PM AEST| By Sam

Elsight gains attention as a defence tech player, supported by rising global drone demand and increasing investment in communication systems critical for autonomous operations and modern military capabilities.

 Is CSL (ASX:CSL) driving ASX 200 healthcare weakness?

Is CSL (ASX:CSL) driving ASX 200 healthcare weakness?

April 22, 2026 05:40 PM AEST| By Sam

Healthcare sector movements and global developments influence ASX market sentiment, with large-cap stocks like CSL shaping broader index dynamics.

 ASX 200 Shocker: Cochlear Crash Deepens After Earnings Blow

ASX 200 Shocker: Cochlear Crash Deepens After Earnings Blow

April 22, 2026 05:36 PM AEST| By Sam

Cochlear shares plunge after a sharp earnings downgrade driven by global headwinds, policy pressures, and weaker demand, highlighting short-term challenges despite ongoing innovation and long-term healthcare demand.

 ASX 200 Biotech Under Pressure: Can CSL Stage a Comeback?

ASX 200 Biotech Under Pressure: Can CSL Stage a Comeback?

April 22, 2026 05:31 PM AEST| By Sam

CSL faces pressure amid earnings challenges and market rotation, though strong plasma therapy demand and global positioning continue to support its long-term outlook within the healthcare sector.

 Why CSL Is Back in Focus Across ASX 100

Why CSL Is Back in Focus Across ASX 100

April 22, 2026 05:24 PM AEST| By Sam

CSL remains central to Australia’s healthcare sector, with its role in biotechnology and global medical supply shaping its position within major equity indices.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.